Almanza-Aguilera, E.; Hernáez, Á.; Corella, D.; Sanllorente, A.; Ros, E.; Portolés, O.; Valussi, J.; Estruch, R.; Coltell, O.; Subirana, I.;
et al. Cancer Signaling Transcriptome Is Upregulated in Type 2 Diabetes Mellitus. J. Clin. Med. 2021, 10, 85.
https://doi.org/10.3390/jcm10010085
AMA Style
Almanza-Aguilera E, Hernáez Á, Corella D, Sanllorente A, Ros E, Portolés O, Valussi J, Estruch R, Coltell O, Subirana I,
et al. Cancer Signaling Transcriptome Is Upregulated in Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 2021; 10(1):85.
https://doi.org/10.3390/jcm10010085
Chicago/Turabian Style
Almanza-Aguilera, Enrique, Álvaro Hernáez, Dolores Corella, Albert Sanllorente, Emilio Ros, Olga Portolés, Julieta Valussi, Ramon Estruch, Oscar Coltell, Isaac Subirana,
and et al. 2021. "Cancer Signaling Transcriptome Is Upregulated in Type 2 Diabetes Mellitus" Journal of Clinical Medicine 10, no. 1: 85.
https://doi.org/10.3390/jcm10010085
APA Style
Almanza-Aguilera, E., Hernáez, Á., Corella, D., Sanllorente, A., Ros, E., Portolés, O., Valussi, J., Estruch, R., Coltell, O., Subirana, I., Canudas, S., Razquin, C., Blanchart, G., Nonell, L., Fitó, M., & Castañer, O.
(2021). Cancer Signaling Transcriptome Is Upregulated in Type 2 Diabetes Mellitus. Journal of Clinical Medicine, 10(1), 85.
https://doi.org/10.3390/jcm10010085